Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diversigen was a microbiome research services company that provided metagenomic sequencing, bioinformatics, statistical analysis, and consulting for studies of human, animal, and environmental microbiomes. Founded in 2013 in Houston, Texas by Joseph Petrosino, the company built a business around sample processing, nucleic acid extraction, sequencing workflow optimization, and interpretation of microbiome data for research and translational applications. OraSure Technologies acquired Diversigen in November 2019 and later combined its microbiome services with CoreBiome under the Diversigen name. The business operated as part of OraSure and DNA Genotek’s microbiome offering, with branded workflows such as BenchMark and BoosterShot. OraSure has since announced that it is exiting the microbiome services business and closing the Diversigen division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diversigen.